|
[1]
|
Ma, T.K., Chow, K.M., Kwan, B.C., et al. (2016) Peritonitis before Peritoneal Dialysis Training: Analysis of Causative Organisms, Clinical Outcomes, Risk Factors, and Long-Term Consequences. Clinical Journal of the American Society of Nephrology, 11, 1219-1226. [Google Scholar] [CrossRef]
|
|
[2]
|
Li, Y.F., Su, N., Chen, S.Y., et al. (2016) Genetic Background of Escherichia coli Isolates from Peritoneal Dialysis Patients with Peritonitis and Uninfected Control Subjects. Genetics and Molecular Research, 15, No. 1. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Feng, X., Yang, X., Yi, C., et al. (2014) Escherichia coli Peritonitis in Peritoneal Dialysis: The Prevalence, Antibiotic Resistance and Clinical Outcomes in a South China Dialysis Center. Peri-toneal Dialysis International, 34f, 308-316. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
吕媛, 李耘, 薛峰, 张秀珍,胡云建, 于庭, 胡志东, 赵建宏, 潘世扬, 胡必杰, 俞云松, 邓秋连, 李艳, 刘文恩, 周玲, 费樱, 府伟, 徐修礼, 裴凤艳, 孟灵, 季萍, 汤进, 欧尾妹. 卫生部全国细菌耐药监测网(Mohnarin) 2011-2012年度血流感染细菌耐药监测报告[J]. 中国临床药理学杂志, 2014, 30(3): 278-288. [Google Scholar] [CrossRef]
|
|
[5]
|
Edey, M., Hawley, C.M., McDonald, S.P., et al. (2010) Enterococcal Peritonitis in Australian Peritoneal Dialysis Patients: Predictors, Treatment and Outcomes in 116 Cases. Nephrology Dialysis Transplantation, 25, 1272-1278. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
韦丽芳, 韦梅娟, 赖珍琼, 韦俏如, 王洁. 微信平台健康教育模式对中青年居家腹膜透析患者焦虑及抑郁的干预效果[J]. 右江医学, 2019, 47(12): 912-915.
|
|
[7]
|
中国医师协会肾脏内科医师分会, 中国中西医结合学会肾脏疾病专业委员会营养治疗指南专家协作组. 中国慢性肾脏病营养治疗临床实践指南(2021版) [J]. 中华医学杂志, 2021, 101(8): 539-559.
|
|
[8]
|
徐玉林, 张春秀. 腹膜透析病人运动干预研究进展[J]. 护理研究, 2020, 34(24): 4429-4432.
|
|
[9]
|
孟秀娟, 吴安华. 如何应对多重耐药菌医院感染的严峻挑战[J]. 中国感染控制杂志, 2019, 18(3): 185-192.
|
|
[10]
|
Li, P.K., et al. (2022) ISPD Peritonitis Guideline Recommenda-tion: 2022 Update on Prevention and Treatment. Peritoneal Dialysis International, 42, 110-153. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Gudiol, C., Ayats, J., Camoez, M., et al. (2013) Increase in Bloodstream Infection due to Vancomycin-Susceptible Enterococcus faecium in Cancer Patients: Risk Factors, Molecular Epidemiology and Outcomes. PLOS ONE, 8, e74734. [Google Scholar] [CrossRef] [PubMed]
|